Skip to search formSkip to main contentSkip to account menu

ursodeoxycholyl lysophosphatidylethanolamide

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Hepatic fat accumulation with disturbed lipid homoeostasis is a hallmark of nonalcoholic fatty liver disease (NAFLD). The bile… 
2015
2015
ABSTRACT The ischemia and reperfusion (I/R) injury that occurs during liver transplantation causes severe complications leading… 
2015
2015
An increase of toxic bile acids such as glycochenodeoxycholic acid occurs during warm ischemia reperfusion causing cholestasis… 
2014
2014
Chronic hepatic inflammation results in liver fibrosis. As effective anti‐fibrogenic agents are lacking, we investigated… 
2013
2013
Ursodeoxycholyl lysophosphatidylethanolamide (UDCA-LPE) is a hepatoprotectant in inhibiting apoptosis, inflammation, and… 
Highly Cited
2012
Highly Cited
2012
Hepatic fat accumulation and changes in lipid composition are hallmarks of nonalcoholic fatty liver disease (NAFLD). As an… 
2012
2012
It has been long known that hepatic synthesis of phosphatidylcholine (PC) is depressed during acute such as carbon tetrachloride… 
2009
2009
A decrease of hepatocellular phosphatidylcholine (PC) is associated with hepatic injury, e.g., in nonalcoholic steatohepatitis… 
1990
1990
The effect of dietary administration of four different amino acid (N‐acyl) conjugates of ursodeoxycholic acid on biliary bile…